Filing Details
- Accession Number:
- 0001209191-12-054148
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-20 18:09:03
- Reporting Period:
- 2012-11-16
- Filing Date:
- 2012-11-20
- Accepted Time:
- 2012-11-20 18:09:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422997 | Petrus Bekker | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Svp Of Medical & Clinical | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-11-16 | 10,000 | $11.90 | 53,594 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-19 | 1,561 | $0.60 | 55,155 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-19 | 1,561 | $12.01 | 53,594 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-20 | 3,439 | $0.60 | 57,033 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-20 | 3,439 | $12.01 | 53,594 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option | Disposition | 2012-11-19 | 1,561 | $0.00 | 1,561 | $0.60 |
| Common Stock | Employee Stock Optin | Disposition | 2012-11-20 | 3,439 | $0.00 | 3,439 | $0.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,939 | 2015-05-05 | No | 4 | M | Direct | |
| 47,500 | 2012-05-05 | No | 4 | M | Direct |
Footnotes
- Includes 1,094 shares acquired under the Issuer's Employee Stock Purchase Plan on November 14, 2012.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $12.00 to $12.05 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of November 19, 2012 and prior to this transaction, the option fully vested.
- Not applicable.
Billionaire Hedge Funds
